Literature DB >> 698698

Natural history and prognosis of recurrent breast cancer.

S Karabali-Dalamaga, R L Souhami, N J O'Higgins, A Soumilas, C G Clark.   

Abstract

Patterns of recurrent disease were analysed in 603 patients with breast cancer. The time of onset, frequency of recurrence, and survival after recurrence were not influenced by age or menopausal state. While survival after local recurrence was longer than survival after distant metastasis, the time to onset of local and distant disease followed an identical pattern, indicating that local recurrence should be regarded as a manifestation of systemic disease. Postoperative radiotherapy did not affect the time of onset of local recurrence. We suggest that patients with local recurrence should receive both systemic and local treatment and that controlled trials of chemotherapeutic agents in these patients might be valuable in finding the most effective drug combinations to be used as adjuvant treatment after mastectomy.

Entities:  

Mesh:

Year:  1978        PMID: 698698      PMCID: PMC1607597          DOI: 10.1136/bmj.2.6139.730

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  6 in total

1.  The curability of breast cancer.

Authors:  M Baum
Journal:  Br Med J       Date:  1976-02-21

2.  Treatment of stage-II carcinoma of the female breast.

Authors:  D Brinkley; S L Haybittle
Journal:  Lancet       Date:  1966-08-06       Impact factor: 79.321

3.  Recent mortality from breast cancer.

Authors:  M J Adams; C C Spicer
Journal:  Lancet       Date:  1965-10-09       Impact factor: 79.321

4.  Treatment of early cancer of the breast: Histological staging and role of radiotherapy.

Authors:  A M McDonald; J S Simpson; J MacIntyre
Journal:  Lancet       Date:  1976-05-22       Impact factor: 79.321

5.  Postoperative radiotherapy in the treatment of breast cancer: results of the NSABP clinical trial.

Authors:  B Fisher; N H Slack; P J Cavanaugh; B Gardner; R G Ravdin
Journal:  Ann Surg       Date:  1970-10       Impact factor: 12.969

6.  Combination chemotherapy as an adjuvant treatment in operable breast cancer.

Authors:  G Bonadonna; E Brusamolino; P Valagussa; A Rossi; L Brugnatelli; C Brambilla; M De Lena; G Tancini; E Bajetta; R Musumeci; U Veronesi
Journal:  N Engl J Med       Date:  1976-02-19       Impact factor: 91.245

  6 in total
  8 in total

1.  Tumor progression- and metastasis-associated proteins identified using a model of locally recurrent rat mammary adenocarcinomas.

Authors:  D R Welch; S A McClure; P A Aeed; M J Bahner; L D Adams
Journal:  Clin Exp Metastasis       Date:  1990 Nov-Dec       Impact factor: 5.150

2.  Breast reconstruction after failed conservation.

Authors:  A G Nash; P R Taylor
Journal:  Ann R Coll Surg Engl       Date:  1985-09       Impact factor: 1.891

3.  Intraosseous metastatic breast cancer treatment with internal fixation and study of survival.

Authors:  A G Gristina; D M Adair; C L Spurr
Journal:  Ann Surg       Date:  1983-02       Impact factor: 12.969

Review 4.  Patterns of recurrence in Western and Japanese women with breast cancer.

Authors:  M A Chaudary
Journal:  Breast Cancer Res Treat       Date:  1991-05       Impact factor: 4.872

5.  Expression of metalloproteases and their inhibitors in primary tumors and in local recurrences after mastectomy for breast cancer.

Authors:  José M del Casar; Guillermo Carreño; Luis O González; Sara Junquera; Salomé González-Reyes; José M González; Miguel Bongera; Antonio M Merino; Francisco J Vizoso
Journal:  J Cancer Res Clin Oncol       Date:  2009-12-30       Impact factor: 4.553

6.  Re-irradiation of the chest wall for local breast cancer recurrence : Results of salvage brachytherapy with hyperthermia.

Authors:  A Auoragh; V Strnad; O J Ott; M W Beckmann; R Fietkau
Journal:  Strahlenther Onkol       Date:  2016-07-05       Impact factor: 3.621

7.  Sensitivity of locally recurrent rat mammary tumour cell lines to syngeneic polymorphonuclear cell, macrophage and natural killer cell cytolysis.

Authors:  P A Aeed; D R Welch
Journal:  Br J Cancer       Date:  1988-12       Impact factor: 7.640

8.  The clinical value of immunohistochemically demonstrable CEA in breast cancer: a possible method of selecting patients for adjuvant chemotherapy.

Authors:  S R Smith; A Howell; A Minawa; J M Morrison
Journal:  Br J Cancer       Date:  1982-11       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.